Tech Company Financing Transactions
Lomond Therapeutics Funding Round
Lomond Therapeutics closed a $20 million funding round on 3/28/2025. Investors included Qatar Investment Authority and Yosemite.
Transaction Overview
Company Name
Announced On
3/28/2025
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8 The Green 8490
Dover, DE 19901
USA
Dover, DE 19901
USA
Phone
Undisclosed
Website
Email Address
Overview
Lomond Therapeutics is a small molecule oncology drug discovery company committed to defeating and curing cancer. Many malignant tumors develop resistance to treatment either by developing mutations or escape mechanisms, thereby limiting the activity of current therapeutics. At Lomond, we develop differentiated small molecules that target fundamental biological pathways with resistant mutations and escape mechanisms in hematologic malignancies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Iain Dukes
Browse more venture capital transactions:
Prev: 3/28/2025: DeCharge venture capital transaction
Next: 3/28/2025: Crusoe venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs